Guangzhou Cancer Treatment Travel: World-Class Radiotherapy Without Leaving China

Cancer is a journey no one chooses, but the right destination can change everything. For international patients weighing their options, Guangzhou has quietly become one of Asia's most compelling centers for advanced radiation oncology — combining world-class equipment, internationally trained specialists, significantly lower treatment costs than Western countries, and a visa system now specifically designed to welcome medical travelers.

This guide focuses on what international patients actually need to know: which technologies are available, what they treat, how much they cost, how to arrange treatment and a visa, and how to organize the logistics of traveling to China for therapy. It is built around the capabilities of Guangzhou's leading radiation oncology centers — facilities that combine internationally trained teams, modern equipment fleets and active international-patient programs — while also covering the wider Guangzhou medical ecosystem so you can make an informed, independent decision.

1. Why Guangzhou for Cancer Treatment

Guangzhou, the capital of Guangdong Province and the heart of the Greater Bay Area, has evolved from a trading hub into one of China's most sophisticated medical cities. For international patients, it offers a rare combination: hospitals that meet Western treatment standards, prices that are a fraction of those in the United States or Western Europe, and a government that has actively built a welcoming framework for medical travelers.

China's inbound medical travel sector has grown dramatically. In 2025, leading hospitals authorized to receive international patients across China treated about 1.28 million foreign patient visits, up 73.6% compared with three years earlier. Of these, roughly 413,000 were patients who traveled to China specifically for medical care — an increase of 63%. Guangzhou sits at the center of this growth, buoyed by its long history of foreign trade, its proximity to Hong Kong, and its status as a major aviation gateway.

What Makes Guangzhou Stand Out for Oncology

• Radiotherapy technology density. Guangzhou's leading radiation oncology centers operate a full fleet of modern systems — CyberKnife, TomoTherapy, TrueBeam, Halcyon, Ethos, brachytherapy — rarely found together even in top-tier Western centers.
• Internationally credentialed teams. Several of the city's centers have been built through Sino-foreign partnerships, with specialists trained in Australia and across Asia, and treatment protocols aligned with MD Anderson, NCCN and CSCO guidelines.
• Substantial cost advantage. Proton therapy in China typically costs 250,000–350,000 RMB (about USD 35,000–49,000) per course versus USD 600,000–900,000 in the United States. Radiotherapy and surgery are similarly a fraction of U.S. prices.
• Medical-friendly visa pathways. The S2 medical visa fast track issues visas in 24–48 hours at 28 designated hospitals, and the 240-hour visa-free transit policy applies across Guangdong.
• A thriving cancer ecosystem. The Sun Yat-sen University Cancer Center (SYSUCC) is one of Asia's largest oncology hospitals, treating more than 10,000 hospitalized cancer cases a year.

Regional Comparison at a Glance

For many patients, the deciding factor is not just technology but the complete pathway: how quickly you can see a specialist, how smoothly the visa process works, how transparent the costs are, and how comfortable the recovery environment feels. Guangzhou scores well on all four — a theme this guide explores in detail.

Guangzhou's medical ecosystem extends far beyond a single hospital, which matters when you want second opinions or multi-disciplinary options. The Sun Yat-sen University Cancer Center (SYSUCC) is one of Asia's largest oncology hospitals, treating more than 10,000 hospitalized cancer cases a year with a deep clinical research base. Nanfang Hospital (Southern Medical University) is a national leader in several oncology fields, and the Guangdong Provincial Hospital of Chinese Medicine — the largest traditional Chinese medicine hospital in the country, founded in 1933 — offers integrative oncology combining evidence-based Western treatment with TCM support such as acupuncture and herbal medicine for symptom control and recovery. This density of institutions means an international patient in Guangzhou can realistically assemble a full care team — radiation oncologist, medical oncologist, surgeon, imaging specialist and rehabilitation support — often within a single district.

There is also a practical geographical advantage. Guangzhou sits at the heart of the Greater Bay Area, connected to Hong Kong by high-speed rail in about 47 minutes and to Macao by a similar corridor, with Guangzhou Baiyun International Airport serving more than 50 direct international destinations. For a patient who wants family nearby during a long treatment course, or who wishes to combine treatment with a gentle recovery break, few Asian medical hubs offer this combination of clinical depth, accessibility and travel flexibility.

2. Guangzhou's Radiation Oncology Centers

Guangzhou's cancer-care landscape is anchored by a cluster of large, modern hospitals, several of which operate purpose-built radiation oncology centers built to the standards of top-tier (三甲) oncology specialist hospitals. These centers bring together internationally trained oncologists, physicists and therapists in daily practice alongside experienced local Chinese specialists, with treatment protocols aligned with leading international guidelines such as MD Anderson, NCCN and CSCO.

Many are developed through Sino-foreign cooperative programs, which means international patients can expect bilingual communication capacity, Western-standard treatment workflows, and active programs specifically designed to receive foreign patients. The centers' stated mission, captured in the bilingual tagline of one flagship facility — "Let patients enjoy world-leading tumor treatment technology without leaving China" — reflects the broader ambition of Guangzhou's medical establishment. Guiding principles across these centers include a multidisciplinary approach, continuous adoption of new technologies, and respect for both patients and medical staff.

Located in Guangzhou's Baiyun district and across the wider metropolitan area, these hospitals are well served by the city's Metro network and multiple bus routes, giving international patients easy access from both the city center and the airport.

Scale of a Flagship Oncology Hospital

To give a sense of scale, a flagship oncology hospital in Guangzhou typically operates more than 1,500 beds, dozens of intensive-care beds, and more than 30 modern operating rooms — several of them hundred-level laminar flow and interventional suites. It hosts specialized centers for oncology, nuclear medicine diagnosis and treatment, minimally invasive surgery, emergency and critical care, rehabilitation, and other disciplines, with hundreds of senior physicians on staff. Several institutions are expanding, with plans for VIP wards within large new complexes, signaling the ambition to serve a growing number of international and high-end patients.

The Radiation Oncology Center

The radiation oncology department is the flagship of the oncology program in these hospitals, built to top-tier specialist standards. As noted above, several centers have been developed as Sino-foreign cooperative programs — bringing internationally trained specialists into daily practice and aligning treatment protocols with MD Anderson, NCCN and CSCO guidelines. For international patients, this means a standard of care and communication that closely matches what they would expect in leading Western centers, at a fraction of the cost.

Getting Around Guangzhou for Treatment

• Metro: Guangzhou's extensive Metro network (18+ lines) reaches every major hospital district; a taxi or ride-hailing trip from any Metro station completes the journey
• From Baiyun Airport: About 40–60 minutes by car depending on traffic; private transfer is recommended for patients
• From Hong Kong: High-speed rail from Hong Kong West Kowloon to Guangzhou South takes about 47 minutes, then connect onward
• City transport: Metered taxis and ride-hailing apps (e.g., Didi, with English interfaces) are widely available and affordable
• International connectivity: Guangzhou Baiyun International Airport (CAN) serves more than 50 direct international destinations

3. Four Major Technology Platforms

Rather than relying on a single machine, Guangzhou's leading oncology programs are built around four integrated platforms that cover the entire cancer care pathway — from diagnosis to treatment to follow-up. This systems-level approach is what distinguishes modern precision oncology from older, single-modality treatment.

Each platform is supported by a complete medical equipment quality-control system and an information-management network, which the centers report keep imaging, dose calculation, treatment delivery and verification all traceable and reproducible — essential for international patients who want records they can take home.

Why an Integrated Platform Model Matters

Many hospitals own one or two modern machines. Far fewer can move a patient seamlessly through diagnosis, simulation, planning, delivery and follow-up within a single, coordinated system. Guangzhou's flagship centers do exactly this: their platforms share a common data and quality-control backbone, so the same imaging that defines the tumor target also feeds the treatment-planning system, and the same physicists and dosimetrists supervise dose calculation across every machine. For an international patient this integration translates into fewer redundant scans, faster decision-making, and a single medical record that follows you from consultation through discharge. It also means that if a case is better served by robotic surgery, cryoablation or embolization rather than external radiation, the switch can be made within the same hospital and the same care team — reducing the coordination burden that so often complicates cross-facility treatment.

4. CyberKnife M6 Radiosurgery

A flagship system found at Guangzhou's leading centers is the Accuray CyberKnife M6, a sixth-generation robotic radiosurgery platform — the first in China to be installed with a fully targeted multi-leaf collimator and dynamic tracking mode. The CyberKnife, installed in 2019 and licensed on July 7, 2020, belongs to the family of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT).

How CyberKnife Works

The CyberKnife delivers high-dose radiation from hundreds of angles using a compact linear accelerator mounted on a robotic arm. Unlike conventional machines that require rigid immobilization, the CyberKnife tracks the tumor in real time — compensating for breathing, slight patient movement, and even changes in tumor position between beams. This lets doctors deliver ablative doses to small, well-defined tumors with sub-millimeter accuracy while sparing surrounding healthy tissue.

Key Advantages

• Non-invasive and painless: No incision, no anesthesia, no sutures, and a very short recovery period with low side effects.
• Short treatment course: Most tumors are treated in only 1–5 sessions, often completed on an outpatient basis.
• Sub-millimeter precision: System error is less than 0.95 mm, meaning a smaller radiation field and less damage to normal tissue.
• Real-time image-guided tracking: Skull tracking for intracranial tumors, spine tracking for paraspinal tumors, and dynamic tracking for tumors that move with breathing.
• Whole-body capability: Treats small benign and malignant tumors in all parts of the body.

Indications

The CyberKnife is used for intracranial and paraspinal tumors, primary and metastatic tumors, trigeminal neuralgia, arteriovenous malformations, head-and-neck tumors, re-irradiation, primary liver tumors unsuitable for surgery, and low- and intermediate-risk prostate cancer, among others. The center's first CyberKnife case was performed on July 10, 2020.

5. TomoTherapy Helical Radiotherapy

The second flagship system is the Accuray Helical TomoTherapy (TOMO) system, a machine that combines a linear accelerator with a spiral CT scanner — the only radiotherapy device in the world that treats cancer using helical CT scanning. The TOMO available at these centers integrates IMRT (intensity-modulated radiotherapy), IGRT (image-guided radiotherapy) and DGRT (dose-guided radiotherapy) into a single platform.

Why TOMO Is Different

Instead of fixed beams from a few angles, TOMO rotates 360 degrees around the patient while the treatment couch moves slowly through the bore, delivering radiation in a continuous helical pattern — the same geometry as a spiral CT scan. The integrated on-board CT provides imaging accuracy of up to ±0.1 mm with dose calculation and verification, ensuring high precision in both position and dose.

Key Advantages

• Imaging precision ±0.1 mm: A CT-comparable imaging system that doubles as a dose verification tool.
• Zero-error co-source dual-beam: Precise image guidance from a system that shares its source geometry with the treatment beam.
• Large scan field: A 135 cm × 40 cm scan range enables treatment of multiple or complex lesions.
• 360-degree helical irradiation: Multi-angle delivery that concentrates dose on tumors and protects vital organs.
• Single-session multi-lesion capability: TOMO can irradiate several tumor foci in one session — a major advantage for complex and challenging tumors.

Clinical data from numerous domestic and international hospitals show that, compared with conventional radiotherapy, helical TomoTherapy is associated with higher survival rates and fewer radiation reactions and complications.

Indications

TOMO has a wide application range and can treat tumors anywhere in the body, with virtually full coverage of cases suitable for radiotherapy — especially intensity-modulated cases. Its main indications include complex head-and-neck tumors, intracranial tumors, common primary tumors, hematopoietic disorders such as leukemia and lymphoma, pituitary tumors, acoustic neuromas, meningiomas, lung cancer, and metastatic disease.

6. TrueBeam, Halcyon and Ethos Adaptive Systems

Beyond CyberKnife and TOMO, Guangzhou's leading centers operate state-of-the-art Varian linear accelerators, each with a distinct clinical role. Together they give these departments the flexibility to match the right machine to the right patient.

Varian TrueBeam

The TrueBeam is a next-generation, image-guided linear accelerator that supports both intensity-modulated radiotherapy (IMRT/VMAT) and stereotactic radiosurgery. Equipped with the latest HyperArc technology, it delivers very high precision and efficiency, dramatically improving the speed and accuracy of treatment. TrueBeam is well suited to nasopharyngeal cancer (a common cancer in southern China), lung, esophageal, breast, central-nervous-system, gastric, primary liver, cervical, prostate, rectal and endometrial cancers, and it can perform stereotactic body radiotherapy (SBRT).

HyperArc Technology

HyperArc is a non-coplanar stereotactic radiosurgery technique developed specifically for intracranial tumors. With sub-millimeter precision, it can treat from several to dozens of brain metastases in a single fraction in about 10 minutes — a major advance for patients with multiple brain lesions. Guangzhou's first HyperArc case was performed on October 28, 2020.

Respiratory Gating

The centers also use respiratory-gated radiotherapy, which tracks the patient's breathing to precisely localize the target, reducing radiation to normal tissue and lowering side effects. It is mainly indicated for lung, liver, breast and abdominal tumors that move with respiration. The first respiratory-gating case in Guangzhou was performed on May 11, 2020.

Varian Halcyon (with HyperSight)

The Halcyon is described as the world's first linear accelerator built for 100% image-guided, fully digital and AI-driven treatment. Its gantry rotates at up to 5 cm/s — roughly four times faster than conventional accelerators — covers 100% of the tumor irradiation area, and completes a full treatment in 6–8 minutes. Its dual-layer high-speed multi-leaf collimator delivers high-intensity modulation with low leakage.

Patients appreciate Halcyon's comfort: a 100 cm large-bore design, noise-reducing intercom, water-cooled quiet interior, and a blue-light guidance system that reduces operator errors.

A notable upgrade took place on September 15, 2025, when one of Guangzhou's centers upgraded its Halcyon to v4.0, becoming the first device in China equipped with HyperSight advanced image-guided technology. This joint Varian–hospital upgrade expands the imaging field from 43 cm × 43 cm to 86 cm × 43 cm, improves image clarity to near-diagnostic level for direct target delineation and dose optimization, and cuts the iCBCT scan time from 15 seconds to 6 seconds — enabling single-breath-hold scanning, eliminating motion artifacts, and allowing real-time adaptive re-planning during treatment. The center's first HyperSight procedure was completed on September 16, 2025.

Varian Ethos — AI Online Adaptive Therapy

Installed in September 2022 and licensed on April 7, 2023, the Ethos is the world's first online adaptive radiotherapy system based on artificial intelligence. Before each treatment, Ethos captures the patient's current anatomy, uses AI to re-target the tumor and re-optimize the plan, and delivers radiation that precisely matches the tumor as it exists that day. The first adaptive case was performed on April 16, 2023.

Ethos is especially valuable for tumors in the prostate, bladder, cervix, endometrium and rectum, whose position varies with bladder and bowel filling. It is also applicable to head-and-neck, lung, esophageal and breast cancer.

A Real Ethos Case Study

A 67-year-old male bladder cancer patient faced a classic adaptive-radiotherapy challenge: the tumor position varied with bladder filling, making reproducibility poor with conventional methods. Using Ethos, clinicians captured a fresh iCBCT image before each session, recontoured the target, and redesigned the plan each day. The result was substantially greater precision than a static plan could achieve — a demonstration of why adaptive therapy is transforming pelvic tumor treatment.

7. Brachytherapy and Other Advanced Modalities

External-beam machines are only half the story. The center also performs brachytherapy (近距离放射治疗) using the Varian GammaMedplus iX — a fifth-generation, high-dose-rate (HDR) afterloader designed specifically for three-dimensional conformal brachytherapy.

What Is Brachytherapy?

Brachytherapy, also called internal radiation therapy or sealed-source radiotherapy, places a radioactive source directly inside or next to the tumor — through a natural body cavity (such as the vagina) or via interstitial insertion. Because the source sits inside the tumor, radiation is delivered at very high dose rate locally while sparing surrounding organs. It can be used alone or combined with surgery, external-beam radiotherapy and chemotherapy.

Benefits and Indications

• Short treatment time: Many sessions can be done on an outpatient basis.
• High safety: Reduces side effects and complications, and lowers the local recurrence rate, extending survival.
• Personalized plans: Clinicians control dose to adjacent organs while maximizing tumor effect.
• Indications: Cervical, endometrial, prostate, rectal, esophageal, oral, pancreatic, liver and lung cancer, plus superficial solid tumors, skin cancer, cholangiocarcinoma and nasopharyngeal carcinoma.

Other Modalities Across the Hospital

The broader oncology program adds even more tools: Da Vinci robotic surgery, DSA hybrid operating rooms, an argon-helium (氩氦) cryoablation system, HIFU (high-intensity focused ultrasound), sonodynamic therapy, a 6th-generation BSD hyperthermia system, and a FreeGS-A gamma knife. This breadth means international patients can often receive integrated, multi-modality care in one hospital instead of shuttling between facilities.

8. Nuclear Medicine and Theranostics

Nuclear medicine — using radioactive substances to both image and treat disease — is central to modern precision oncology. The nuclear medicine departments at Guangzhou's leading centers bring together experienced teams and combine radionuclide therapy with PET imaging, including some of the most advanced theranostic (diagnostic-and-therapeutic) programs in southern China.

Radionuclide (Radioisotope) Therapies

The department also performs I-125 seed implantation for local tumor control and participates in Lutetium-177-based treatments, with dedicated Y-90 observation wards (4 rooms).

Advanced PET Imaging

Imaging is equally advanced. The hospital operates a Siemens Biograph Vision Quadra PET/MRI (fourth-generation "Compass" technology) with exceptionally high detection sensitivity, whole-body scans in about 5 minutes, ultra-low radiation dose, and motion-artifact removal without gating. It is complemented by a Siemens 52-ring PET/CT and a PET/CT from United Imaging.

Its in-house positive-electron radiopharmaceutical preparation center, built to GMP standards and licensed by the Guangdong Provincial Medical Products Administration, operates a Sumitomo HM-10HC+ medical cyclotron (10 MeV) with six targets (18F, 11C, 13N, 68Ga, 64Cu, 89Zr) and produces 39 different positron tracers. This covers the full suite of tumor imaging — including FDG, FAPI, PSMA, DOTATATE, amino-acid and hypoxia tracers — a capability few hospitals in the region can match, and one that crucially enables theranostics workflows where the same tracer first images, then guides, therapy.

Theranostics: Imaging and Treating in One Visit

One of the most rapidly growing fields in oncology is theranostics — the pairing of a diagnostic tracer with a therapeutic radionuclide that targets the same molecule. The center's in-house cyclotron and PET infrastructure make such paired workflows practical in a single institution. For example, the same Gallium-68 PSMA imaging that maps prostate-cancer metastases can guide subsequent targeted radiotherapy; Iodine-131 SPECT-CT fusion helps locate and then treat differentiated thyroid-cancer metastases; and Y-90 resin microsphere planning uses Technetium-99m MAA mapping on SPECT-CT to calculate the exact dose distribution before the therapeutic injection. For international patients this means fewer hospital visits, a shorter overall stay, and a clearer picture of exactly where the disease is and how it will be treated — before treatment even begins.

The Y-90 Liver Program

Liver cancer and colorectal liver metastases are among the most common indications that bring patients to a hepatobiliary-focused center. The Y-90 selective internal radiation therapy (SIRT) program at Guangzhou's leading centers is a good example of the integrated model at work: interventional radiologists administer the microspheres through the hepatic artery under DSA guidance, while nuclear-medicine physicians handle the pre-treatment dosimetry mapping and post-treatment assessment. Dedicated Y-90 observation wards (four rooms) allow patients to recover safely while radioactivity decays, and follow-up PET-CT confirms the delivered dose distribution. This end-to-end capability — planning, delivery, inpatient observation and response assessment — is exactly what international patients should look for when comparing liver-tumor programs across Asia.

9. The Radiotherapy Journey Step by Step

Understanding the workflow ahead of time reduces anxiety and helps you plan your stay. Here is what a typical course of radiotherapy at the center looks like:

Preparing Your Records for the First Review

The quality of your initial medical review depends directly on what you send. Before contacting a Guangzhou hospital or a coordinating agency, gather a complete, organized packet: the pathology report and slides (or digital whole-slide images) confirming the diagnosis; recent imaging studies in DICOM format on a USB drive or cloud link, including CT, MRI and PET-CT if available; a summary of all prior treatments with dates, drugs, doses and any toxicities; current medications; and a list of other medical conditions. If slides and imaging are large, most hospitals accept secure cloud transfers arranged by an agency. Having everything ready in English (or with a translated summary) can shorten the pre-travel MDT review from days to a matter of hours, and it dramatically improves the accuracy of the treatment recommendation you receive before you fly.

10. Multidisciplinary Tumor Boards (MDT)

Modern oncology is too complex for any single specialist. The center operates a formal multidisciplinary treatment (MDT) model: a working team with experts from surgical oncology, medical oncology, radiation oncology, radiology and pathology meets regularly to review each case and propose the optimal plan.

In the traditional patient journey, a patient is shuffled between separate departments and specialists. In the MDT model, the team comes to the patient. The patient's specific needs — tumor biology, imaging, staging, existing conditions, and personal preferences — are reviewed by the whole relevant team in one coordinated discussion, and a unified plan is delivered. This is the standard of care at the world's leading cancer centers and is a key reason the center's outcomes compare favorably with international benchmarks.

For international patients, the MDT approach means you get a second-opinion-style, comprehensive review by multiple specialists as a matter of routine, not as an add-on service — and your case can be discussed across language barriers with the bilingual team before you ever fly to Guangzhou.

What to Expect in Your First MDT Review

If you send your records in advance, the center can pre-convene a tumor-board discussion so that by the time you arrive, the team already knows your case. Expect the review to cover: confirmation of the pathological diagnosis (including whether a second pathology read is advised), re-staging based on fresh imaging, an assessment of prior treatment and its toxicities, and a recommendation of the primary modality — radiation, surgery, systemic therapy, or a combination — with the specific machine and fractionation scheme if radiation is recommended. You will typically receive this as a written consultation summary, which you can share with your home oncologist. This pre-travel review is one of the strongest arguments for working with a coordinating agency: it lets you make a fully informed decision about whether to travel, and how long to stay, before committing to flights and visas.

11. Proton Therapy in China and Guangzhou

Proton therapy is the most precise form of radiotherapy available today. Unlike X-ray (photon) radiation, protons deposit most of their energy at a precise depth — the "Bragg peak" — allowing doctors to deliver a high dose to the tumor and nearly zero dose beyond it. This is particularly beneficial for tumors near critical organs, for pediatric patients (reducing risk of secondary cancers and developmental damage), and for re-irradiation.

A Historic Step for Guangzhou

In 2024, a Guangzhou hospital obtained one of southern China's first proton radiotherapy configuration licenses — a significant milestone for the region. The facility is installing a MEVION S250i proton therapy system and, at the time of writing, plans to complete installation and commissioning in 2026. Initial clinical programs will focus on pediatric tumors and skull-base tumors, with a target of serving about 2,000 patients per year once fully operational.

This matters for international patients because Guangzhou has historically lacked in-city proton therapy, forcing patients to travel to Shanghai or abroad. When the Guangzhou proton center opens, it will put world-class proton therapy directly in the heart of the Greater Bay Area.

Proton Costs Across China vs. the World

How to Judge Whether Proton Therapy Is Worth the Extra Cost

Proton therapy typically costs several times more than photon (X-ray) radiotherapy, so the decision deserves a careful, evidence-based discussion rather than a marketing instinct. Strong candidates for protons include: pediatric tumors, where reducing radiation to growing tissues lowers the lifetime risk of secondary cancers; skull-base and other tumors abutting critical structures such as the optic nerves, brainstem or spinal cord; and re-irradiation, where normal tissue tolerance has already been partially consumed by earlier treatment. By contrast, for many common adult tumors — early-stage prostate cancer, localized lung cancer, most head-and-neck cancers — modern photon techniques such as IMRT, VMAT, SBRT and CyberKnife achieve comparable local control with acceptable toxicity, at a fraction of the cost. Ask your oncologist the direct question: "Would proton therapy change my prescribed dose, my expected control rate, or my risk of side effects compared with the best photon plan?" If the honest answer is no, a modern photon system may be the smarter investment of your treatment budget — a decision the multidisciplinary team can help you make with real dosimetry, not generalities.

12. Treatment Costs and Value Comparison

Cost is often the single largest driver for international patients choosing China. The figures below are reasonable planning estimates drawn from current market data; always obtain a written quote from the hospital for your specific protocol.

Why the Price Difference Is So Large

China's cost advantage comes from several factors: lower labor costs for highly skilled staff, government-subsidized public hospitals, a large domestic market that drives equipment utilization, and domestically produced alternatives to imported devices. Translated into patient terms, the same modern radiotherapy that might cost six figures in the United States is typically one-quarter to one-third the price in Guangzhou — often without sacrificing technology or expertise, since many machines are the identical imported models (Varian, Accuray, Siemens) used in the West.

Payment, Deposits and Refunds

International patients should understand how hospital billing works before arrival to avoid surprises. Most Chinese hospitals ask international patients to prepay treatment costs, usually by bank transfer or credit card, and issue itemized receipts as treatment proceeds; any unused balance is refunded at discharge. It is worth asking for a written treatment plan that itemizes simulation, planning, daily fractions, imaging and physician fees, so you know what the prepayment covers. Keep every receipt — they are needed for any follow-up claims and for documentation of the out-of-pocket expenses that many home-country tax or insurance processes require. Ask explicitly whether an international department exists, because some hospitals run separate pricing and billing tracks for foreign patients; knowing this in advance lets you compare the public and international options realistically.

Insurance, Medical Tourism and Out-of-Pocket Planning

Before assuming anything about coverage, check three things with your insurer: whether it covers treatment received abroad at all; whether a pre-authorization or treatment-invitation letter is required; and whether it reimburses on a claims basis (pay-and-reclaim) or through a direct-billing arrangement. Many international policies exclude overseas treatment unless arranged in advance, while a growing number of insurers now include Asia medical-tourism riders. If you are largely self-paying, negotiate a clear package quote before traveling and keep the treatment plan as your reference. Regardless of coverage, purchase a comprehensive travel medical policy that includes emergency repatriation — radiotherapy side effects are usually manageable, but a serious intercurrent event should not leave you financially exposed in a foreign country.

13. Visas and the S2 Medical Visa Fast Track

China has made it significantly easier for international patients to enter for treatment. Understanding the visa landscape is one of the most important steps in planning your trip.

The S2 Medical Visa (Fast Track)

The S2 visa is China's visa category for short-term personal visits, including medical treatment. In 2026, China introduced a fast-track medical visa** process at 28 designated hospitals: qualified patients receive visa processing in 24–48 hours instead of the usual days. The S2 visa can be issued for stays of up to 180 days, which comfortably covers long radiotherapy courses.